Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. (atsiveria naujas langas)

Ahmadi T, Chong EA, Gordon A, Aqui NA, Nasta SD, Svoboda J, Mato AR, Schuster SJ.

Šaltinis‎: Cancer 2014;120(2):222-8.

Kodas‎: PubMed 24122387

DOI‎: 10.1002/cncr.28405

https://www.ncbi.nlm.nih.gov/pubmed/24122387 (atsiveria naujas langas)

Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (atsiveria naujas langas)

Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.

Šaltinis‎: J Clin Oncol 2004;22(20):4087-94.

Kodas‎: PubMed 15353543

DOI‎: 10.1200/JCO.2004.01.144

https://www.ncbi.nlm.nih.gov/pubmed/15353543 (atsiveria naujas langas)

Leucemia aguda en los Testigos de Jehová. [Acute leukemia in Jehovah's Witnesses.] [Spanish] (atsiveria naujas langas)

Bueno J, Zuazu J, Villalba T, Julià A.

Šaltinis‎: Sangre (Barc) 1999;44(5):381-2.

Kodas‎: PubMed 10618916

https://www.ncbi.nlm.nih.gov/pubmed/10618916 (atsiveria naujas langas)

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (atsiveria naujas langas)

Ciurea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, Peace D.

Šaltinis‎: Bone Marrow Transplant 2006;37(3):325-7.

Kodas‎: PubMed 16314850

DOI‎: 10.1038/sj.bmt.1705223

https://www.ncbi.nlm.nih.gov/pubmed/16314850 (atsiveria naujas langas)

Oral azacitidine (CC-486) for the treatment of myelodysplastic syndromes and acute myeloid leukemia. (atsiveria naujas langas)

Cogle CR, Scott BL, Boyd T, Garcia-Manero G.

Šaltinis‎: Oncologist 2015;20(12):1404-12.

Kodas‎: PubMed 26463870

DOI‎: 10.1634/theoncologist.2015-0165

https://www.ncbi.nlm.nih.gov/pubmed/26463870 (atsiveria naujas langas)

Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. (atsiveria naujas langas)

Corsetti MT, Salvi F, Perticone S, Baraldi A, De Paoli L, Gatto S, Pietrasanta D, Pini M, Primon V, Zallio F, Tonso A, Alvaro MG, Ciravegna G, Levis A.

Šaltinis‎: Leuk Res 2011;35(8):991-7.

Kodas‎: PubMed 21474179

DOI‎: 10.1016/j.leukres.2011.02.021

https://www.ncbi.nlm.nih.gov/pubmed/21474179 (atsiveria naujas langas)

Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. (atsiveria naujas langas)

Coutre SE, Othus M, Powell B, Willman CL, Stock W, Paietta E, Levitan D, Wetzler M, Attar EC, Altman JK, Gore SD, Maher T, Kopecky KJ, Tallman MS, Larson RA, Appelbaum FR.

Šaltinis‎: Br J Haematol 2014;165(4):497-503.

Kodas‎: PubMed 24528179

DOI‎: 10.1111/bjh.12775

https://www.ncbi.nlm.nih.gov/pubmed/24528179 (atsiveria naujas langas)

Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses. (atsiveria naujas langas)

Dainer PM, Knupp CL, Sartiano GP.

Šaltinis‎: Am J Hematol 1992;40(2):156-7.

Kodas‎: PubMed 1585917

https://www.ncbi.nlm.nih.gov/pubmed/1585917 (atsiveria naujas langas)

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. (atsiveria naujas langas)

Delarue R, Tilly H, Mounier N, Petrella T, Salles G, Thieblemont C, Bologna S, Ghesquières H, Hacini M, Fruchart C, Ysebaert L, Fermé C, Casasnovas O, Van Hoof A, Thyss A, Delmer A, Fitoussi O, Molina TJ, Haioun C, Bosly A.

Šaltinis‎: Lancet Oncol 2013;14(6):525-33.

Kodas‎: PubMed 23578722

DOI‎: 10.1016/S1470-2045(13)70122-0

https://www.ncbi.nlm.nih.gov/pubmed/23578722 (atsiveria naujas langas)

Azacitidine and venetoclax in previously untreated acute myeloid leukemia. (atsiveria naujas langas)

DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW

Šaltinis‎: N Engl J Med 2020;383(7):617-29.

Kodas‎: PubMed 32786187

DOI‎: 10.1056/NEJMoa2012971

https://www.ncbi.nlm.nih.gov/pubmed/32786187 (atsiveria naujas langas)

Treatment of acute leukaemia in adult Jehovah's Witnesses. (atsiveria naujas langas)

El Chaer F, Ballen KK

Šaltinis‎: Br J Haematol 2020;190(5):696-707.

Kodas‎: PubMed 31693175

DOI‎: 10.1111/bjh.16284

https://www.ncbi.nlm.nih.gov/pubmed/31693175 (atsiveria naujas langas)

Minimally-myelosuppressive asparaginase-containing induction regimen for treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS acute myeloid leukemia. (atsiveria naujas langas)

Emadi A, Bade NA, Stevenson B, Singh Z.

Šaltinis‎: Pharmaceuticals (Basel) 2016;9(1):E12.

Kodas‎: PubMed 27064021

DOI‎: 10.3390/ph9010012

https://www.ncbi.nlm.nih.gov/pubmed/27064021 (atsiveria naujas langas)

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. (atsiveria naujas langas)

Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T.

Šaltinis‎: J Clin Oncol 2009;27(28):4733-40.

Kodas‎: PubMed 19720927

DOI‎: 10.1200/JCO.2008.19.8721

https://www.ncbi.nlm.nih.gov/pubmed/19720927 (atsiveria naujas langas)

Successful treatment of a Jehovah's Witness with acute promyelocytic leukemia. (atsiveria naujas langas)

Fujita H, Maruta A, Koharazawa H, Hattori M, Tomit N, Kodama F, Mohri H, Okubo T.

Šaltinis‎: Int J Hematol 1997;65(4):415-6.

Kodas‎: PubMed 9195782

https://www.ncbi.nlm.nih.gov/pubmed/9195782 (atsiveria naujas langas)

Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia. (atsiveria naujas langas)

Garelius H, Grund S, Stockelberg D.

Šaltinis‎: Clin Case Rep 2015;3(5):287-90.

Kodas‎: PubMed 25984306

https://www.ncbi.nlm.nih.gov/pubmed/25984306 (atsiveria naujas langas)

Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness? (atsiveria naujas langas)

Juliusson G.

Šaltinis‎: Am J Hematol 1996;53(1):49.

Kodas‎: PubMed 8813099

DOI‎: 10.1002/(SICI)1096-8652(199609)53:1<49::AID-AJH12>3.0.CO;2-Z

https://www.ncbi.nlm.nih.gov/pubmed/8813099 (atsiveria naujas langas)

Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat. (atsiveria naujas langas)

Laszlo D, Agazzi A, Goldhirsch A, Cinieri S, Bertolini F, Rabascio C, Pruneri G, Calabrese L, Cocquio A, Martinelli G.

Šaltinis‎: Eur J Haematol 2004;72(4):264-7.

Kodas‎: PubMed 15089764

DOI‎: 10.1111/j.0902-4441.2003.00211.x

https://www.ncbi.nlm.nih.gov/pubmed/15089764 (atsiveria naujas langas)

Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin. (atsiveria naujas langas)

Lin CP, Huang MJ, Liu HJ, Chang IY, Tsai CH.

Šaltinis‎: Am J Hematol 1996;51(3):251-2.

Kodas‎: PubMed 8619417

DOI‎: 10.1002/(SICI)1096-8652(199603)51:3<251::AID-AJH20>3.0.CO;2-I

https://www.ncbi.nlm.nih.gov/pubmed/8619417 (atsiveria naujas langas)

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. (atsiveria naujas langas)

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

Šaltinis‎: Hematol Oncol 2014;32(1):40-6.

Kodas‎: PubMed 23963734

DOI‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 (atsiveria naujas langas)

Cytarabine dose for acute myeloid leukemia. (atsiveria naujas langas)

Löwenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Biemond BJ, Gratwohl A, de Greef GE, Verdonck LF, Schaafsma MR, Gregor M, Theobald M, Schanz U, Maertens J, Ossenkoppele GJ; Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group.

Šaltinis‎: N Engl J Med 2011;364(11):1027-36.

Kodas‎: PubMed 21410371

DOI‎: 10.1056/NEJMoa1010222

https://www.ncbi.nlm.nih.gov/pubmed/21410371 (atsiveria naujas langas)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (atsiveria naujas langas)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Šaltinis‎: Bone Marrow Transplant 2003;32(4):433-6.

Kodas‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (atsiveria naujas langas)

Ivosidenib and azacitidine in IDH1-mutated acute myeloid leukemia. (atsiveria naujas langas)

Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh SP, Daigle SR, Hui J, Pandya SS, Gianolio DA, de Botton S, Döhner H

Šaltinis‎: N Engl J Med. 2022;386(16):1519-31. 

Kodas‎: PubMed 35443108

DOI‎: 10.1056/NEJMoa2117344

https://pubmed.ncbi.nlm.nih.gov/35443108/ (atsiveria naujas langas)

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer. (atsiveria naujas langas)

Nagel CI, Backes FJ, Hade EM, Cohn DE, Eisenhauer EL, O'Malley DM, Fowler JM, Copeland LJ, Salani R.

Šaltinis‎: Gynecol Oncol 2012;124(2):221-4.

Kodas‎: PubMed 22055764

DOI‎: 10.1016/j.ygyno.2011.10.003

https://www.ncbi.nlm.nih.gov/pubmed/22055764 (atsiveria naujas langas)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (atsiveria naujas langas)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Šaltinis‎: Leuk Res Rep. 2022 25;18:100355.

Kodas‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (atsiveria naujas langas)

Developing a blood conservation care plan for Jehovah's Witness patients with malignant disease. (atsiveria naujas langas)

Norfolk DR, Wade P, Carter R.

Šaltinis‎: Presented at the British Society for Haematology 47th Annual Scientific Meeting, Bournemouth [UK] April 2007.

https://www.transfusionguidelines.org/document-library/documents/developing-a-blood-conservation-care-plan-for-jehovah-s-witness-patients-with-malignant-disease/download-file/bbt-JW-Care-Plan-Malignant-Disease-2012.pdf (atsiveria naujas langas)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (atsiveria naujas langas)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Šaltinis‎: Leuk Lymphoma. 2019;60(9):2324-7.

Kodas‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (atsiveria naujas langas)

Hematopoietic growth factors: personalization of risks and benefits. (atsiveria naujas langas)

Puhalla S, Bhattacharya S, Davidson NE.

Šaltinis‎: Mol Oncol 2012;6(2):237-41.

Kodas‎: PubMed 22497867

DOI‎: 10.1016/j.molonc.2012.03.001

https://www.ncbi.nlm.nih.gov/pubmed/22497867 (atsiveria naujas langas)

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. (atsiveria naujas langas)

Riedell PA, Wu M, Collins JM, Gideon JM, Jakubowiak AJ, Kline JP, Kosuri S, Liu H, Smith SM, Bishop MR

Šaltinis‎: Leuk Lymphoma 2021;62(6):1497-501.

Kodas‎: PubMed 33535838

DOI‎: 10.1080/10428194.2021.1876868

https://www.ncbi.nlm.nih.gov/pubmed/33535838 (atsiveria naujas langas)

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia. (atsiveria naujas langas)

Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM

Šaltinis‎: Blood 2020;135(7):463-71.

Kodas‎: PubMed 31841594

DOI‎: 10.1182/blood.2019002140

https://www.ncbi.nlm.nih.gov/pubmed/31841594 (atsiveria naujas langas)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (atsiveria naujas langas)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Šaltinis‎: Bone Marrow Transplant 2005;36(8):715-20.

Kodas‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (atsiveria naujas langas)

A Mexican way to cope with stem cell grafting. (atsiveria naujas langas)

Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Šaltinis‎: Hematology 2012;17 Suppl 1:S195-7.

Kodas‎: PubMed 22507819

DOI‎: 10.1179/102453312X13336169157130

https://www.ncbi.nlm.nih.gov/pubmed/22507819 (atsiveria naujas langas)

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (atsiveria naujas langas)

Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F.

Šaltinis‎: Blood 2009;113(9):1875-91.

Kodas‎: PubMed 18812465

DOI‎: 10.1182/blood-2008-04-150250

https://www.ncbi.nlm.nih.gov/pubmed/18812465 (atsiveria naujas langas)

SCT in Jehovah's Witnesses: the bloodless transplant. (atsiveria naujas langas)

Sloan JM, Ballen K.

Šaltinis‎: Bone Marrow Transplant 2008;41(10):837-44.

Kodas‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (atsiveria naujas langas)

Treatment of acute myelogenous leukemia with outpatient azacitidine. (atsiveria naujas langas)

Sudan N, Rossetti JM, Shadduck RK, Latsko J, Lech JA, Kaplan RB, Kennedy M, Gryn JF, Faroun Y, Lister J.

Šaltinis‎: Cancer 2006;107(8):1839-43.

Kodas‎: PubMed 16967444

DOI‎: 10.1002/cncr.22204

https://www.ncbi.nlm.nih.gov/pubmed/16967444 (atsiveria naujas langas)

Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's Witness. (atsiveria naujas langas)

van Akkooi AC, Golab-Schwarz HD, Eggermont AM, van Geel AN.

Šaltinis‎: Eur J Cardiothorac Surg 2006;30(2):408-10.

Kodas‎: PubMed 16829108

DOI‎: 10.1016/j.ejcts.2006.04.020

https://www.ncbi.nlm.nih.gov/pubmed/16829108 (atsiveria naujas langas)

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes. (atsiveria naujas langas)

Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA.

Šaltinis‎: Onco Targets Ther 2013;7:13-21.

Kodas‎: PubMed 24368888

DOI‎: 10.2147/OTT.S53348

https://www.ncbi.nlm.nih.gov/pubmed/24368888 (atsiveria naujas langas)

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. (atsiveria naujas langas)

Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS.

Šaltinis‎: J Clin Oncol 2007;25(30):4722-9.

Kodas‎: PubMed 17947719

DOI‎: 10.1200/JCO.2007.12.2440

https://www.ncbi.nlm.nih.gov/pubmed/17947719 (atsiveria naujas langas)

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. (atsiveria naujas langas)

Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P

Šaltinis‎: Blood 2020;135(24):2137-45.

Kodas‎: PubMed 32219442

DOI‎: 10.1182/blood.2020004856

https://www.ncbi.nlm.nih.gov/pubmed/32219442 (atsiveria naujas langas)

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. (atsiveria naujas langas)

Weissinger F, Sandmaier BM, Maloney DG, Bensinger WI, Gooley T, Storb R.

Šaltinis‎: Blood 2001;98(13):3584-8.

Kodas‎: PubMed 11739160

https://www.ncbi.nlm.nih.gov/pubmed/11739160 (atsiveria naujas langas)

A Jehovah's Witness with acute myeloid leukemia successfully treated with an epigenetic drug, azacitidine: a clue for development of anti-AML therapy requiring minimum blood transfusions. (atsiveria naujas langas)

Yamamoto Y, Kawashima A, Kashiwagi E, Ogata K.

Šaltinis‎: Case Rep Hematol 2014;2014:141260.

Kodas‎: PubMed 25371835

DOI‎: 10.1155/2014/141260

https://www.ncbi.nlm.nih.gov/pubmed/25371835 (atsiveria naujas langas)

Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma. (atsiveria naujas langas)

Zhou L, Mohsen A, Khan MA, Guthrie T.

Šaltinis‎: J Chemother 2014;26(3):184-6.

Kodas‎: PubMed 24621157

DOI‎: 10.1179/1973947813Y.0000000130

https://www.ncbi.nlm.nih.gov/pubmed/24621157 (atsiveria naujas langas)

Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. (atsiveria naujas langas)

Zhu HH, Wu DP, Jin J, Li JY, Ma J, Wang JX, Jiang H, Chen SJ, Huang XJ.

Šaltinis‎: J Clin Oncol 2013;31(33):4215-21.

Kodas‎: PubMed 24127444

DOI‎: 10.1200/JCO.2013.48.8312

https://www.ncbi.nlm.nih.gov/pubmed/24127444 (atsiveria naujas langas)